Oh look, it’s 2016 Fringe First winners Sh!t Theatre again. What is it this time? Oh, is it unemployment? Is there a crisis? Did the government do something wrong? No, it’s a show about Dolly Parton. Sh!t Theatre f*cking love Dolly Parton and this is the story of their trip to the first lady of country’s theme park, DollyWood. This sharp and hilarious performance takes you on an adventure into the heartland of the US Deep South and beyond to explore real and plastic, mortality and immortality, original and clone.

DollyWouldThe inimitable duo head to Knoxville, Tennessee to Dollywood, built on Dolly Parton’s former childhood home, and while there try to visit the Knoxville Body Farm, the forensic medical facility which researches human decomposition. One is plastic immortality, the other the inescapable reality of death. Enlisting the expertise of the ‘Nigella of science’ genetic scientist Dr Kat Arney, Sh!t Theatre explore the enigma that is Dolly and her namesake Dolly the sheep in this rollercoaster ride of a show complete with live music and sing-a-longs.

Following a Fringe First award-winning sell-out show, Sh!t Theatre return to Belfast from 12-13 October with this bold new show about country legend Dolly Parton, cloning, branding, immortality and death.

Devised and performed by Rebecca Biscuit and Louise Mothersole, this show promises music, silliness and hilarity and will be at Belfast’s The MAC theatre from 12 – 13 October. Tickets are £12 – £25 and are available here.

Laura Caldwell

Author: Laura Caldwell

Hi, I'm Laura. I'm 30 years old and have a degree in Journalism with Photo-Imaging at the University of Ulster. I have an undying love for Belfast and all that it has to offer, an undying love for sleeping, Tegan and Sara, trashy tv shows, foreign snack-foods and being irresponsible with money. I also quite like origami, reading, jazz, hip-hop, dubstep, anything acoustic and Food Network TV. I've written for The Big List, Culture NI, Chatterbox and The Echo, as well as writing for BBC Across the Line.